Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/6/18 16:33 | 1/30/18 | BIOC | Health | Health | Medical Laboratories | Gerhardt Bruce | CA | D | P.d | 0 | 0.00 | 0 | 25 | 34 | 98 | D | |||||||||||||||
3/29/17 16:54 | 3/16/15 | BIOC | Health | Health | Medical Laboratories | Royston Ivor | CA | D | P | 50 | 8.76 | 3 | 6 | 49 | 17 | D | -67 | -46 | 20 | 158 | -1 | -8 | -5 | -6 | -2 | -3 | -22 | ||||
10/21/16 18:43 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Nall Michael W. | CA | DO | CEO,P | P.d | 40 | 1.10 | 0 | 36 | 95 | 75 | M | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | |
10/21/16 18:18 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Chandler Marsha Alpert | CA | D | P.d | 5 | 1.10 | 0 | 5 | 193 | 7 | M | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | ||
10/21/16 18:17 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Kennedy Timothy | CA | O | CFO,SVP | P.d | 40 | 1.10 | 0 | 36 | 145 | 61 | D | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | |
10/21/16 18:16 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Huebner Bruce A | CA | D | P.d | 22 | 1.10 | 0 | 20 | 500 | 24 | D | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | ||
10/21/16 18:15 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Gerhardt Bruce | CA | D | P.d | 55 | 1.10 | 0 | 50 | 215 | 73 | D | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | ||
10/21/16 18:14 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Singh Veena | CA | O | SVP,Sr M | P.d | 11 | 1.10 | 0 | 10 | 55 | 28 | D | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | |
10/21/16 18:12 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Arnold Lyle J | CA | O | SVP of R | P.d | 50 | 1.10 | 0 | 45 | 222 | 65 | D | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | |
10/21/16 18:11 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Wilson Margaret Faye | CA | D | P.d | 15 | 1.10 | 0 | 14 | 107 | 26 | D | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | ||
10/21/16 18:06 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Reiss Claire | CA | T | P.d | 250 | 1.10 | 0 | 227 | 28 | 1,051 | I | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | ||
10/21/16 17:06 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Neff Edward A. | CA | D | P.d | 250 | 1.10 | 0 | 227 | 227 | 327 | I | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | ||
10/21/16 17:04 | 10/19/16 | BIOC | Health | Health | Medical Laboratories | Hale David F | CA | D | P.d | 100 | 1.10 | 0 | 91 | 117 | 169 | I | -89 | -87 | -76 | -48 | -46 | -39 | -29 | 7 | 6 | 7 | -3 | 58 | 82 | ||
5/5/16 20:29 | 5/4/16 | BIOC | Health | Health | Medical Laboratories | Hale David F | CA | D | P.d | 50 | 1.00 | 0 | 50 | 27 | 233 | D | -82 | -69 | -59 | -38 | -31 | -27 | -32 | -9 | -11 | -9 | -33 | -29 | -70 | ||
5/5/16 20:28 | 5/4/16 | BIOC | Health | Health | Medical Laboratories | Neff Edward A. | CA | D | P.d | 100 | 1.00 | 0 | 100 | 50 | 300 | D | -82 | -69 | -59 | -38 | -31 | -27 | -32 | -9 | -11 | -9 | -33 | -29 | -70 | ||
5/5/16 20:27 | 5/4/16 | BIOC | Health | Health | Medical Laboratories | Gerhardt Bruce | CA | D | P.d | 25 | 1.00 | 0 | 25 | 74 | 59 | D | -82 | -69 | -59 | -38 | -31 | -27 | -32 | -9 | -11 | -9 | -33 | -29 | -70 | ||
5/5/16 20:26 | 5/4/16 | BIOC | Health | Health | Medical Laboratories | Reiss Claire | CA | T | P.d | 614 | 1.00 | 0 | 614 | 33 | 2,472 | I | -82 | -69 | -59 | -38 | -31 | -27 | -32 | -9 | -11 | -9 | -33 | -29 | -70 | ||
6/2/15 14:04 | 5/29/15 | BIOC | Health | Health | Medical Laboratories | Singh Veena | CA | O | SVP,Sr M | P.m | 15 | 3.08 | 2 | 5 | New | 5 | I | -26 | 0 | -10 | -2 | 8 | 13 | 9 | 2 | -1 | -22 | -40 | -43 | -81 | |
2/18/15 14:05 | 2/13/15 | BIOC | Health | Health | Medical Laboratories | Wilson Margaret Faye | CA | D | P.d | 5 | 1.25 | 0 | 4 | 45 | 13 | D | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 | ||
2/18/15 14:04 | 2/13/15 | BIOC | Health | Health | Medical Laboratories | Royston Ivor | CA | D | P.d | 15 | 1.25 | 0 | 12 | 247 | 17 | I | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 | ||
2/18/15 14:04 | 2/13/15 | BIOC | Health | Health | Medical Laboratories | Neff Edward A. | CA | D | P.d | 50 | 1.25 | 0 | 40 | 26 | 192 | I | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 | ||
2/18/15 14:03 | 2/13/15 | BIOC | Health | Health | Medical Laboratories | Nall Michael W. | CA | DO | CEO,P | P.d | 15 | 1.25 | 0 | 12 | New | 12 | D | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 | |
2/18/15 14:02 | 2/13/15 | BIOC | Health | Health | Medical Laboratories | Huebner Bruce A | CA | D | P.d | 15 | 1.25 | 0 | 12 | New | 12 | D | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 | ||
2/18/15 14:01 | 2/13/15 | BIOC | Health | Health | Medical Laboratories | Hale David F | CA | DO | CB | P.d | 50 | 1.25 | 0 | 40 | 62 | 105 | I | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 | |
2/18/15 14:01 | 2/13/15 | BIOC | Health | Health | Medical Laboratories | Gerhardt Bruce | CA | D | P.d | 25 | 1.25 | 0 | 20 | 381 | 25 | D | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 | ||
2/18/15 14:00 | 2/13/15 | BIOC | Health | Health | Medical Laboratories | Chandler Marsha Alpert | CA | D | P.d | 3 | 1.25 | 0 | 2 | 39 | 7 | D | -85 | -70 | -60 | -44 | -39 | -21 | 16 | 10 | 144 | 65 | 116 | 34 | -1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |